Correction for you.
PE on ASX is based on profit, not gross sales EBOTI. So where you say 750 per unit... that is a gross sales price, and need to take all costs out of that first, then apply tax, then use the new figure ( I was using $200 ). And back convert to aud.
However, agree I think SP will be somewhere in the single digits by next year. I hope the company release the sales data so we can more or less compare success against Kaken.
Well done to everyone who held over that decision. It took some intestinal fortitude for sure, but in 5 years time I bet everyone will be looking at BOT graph saying, I wish I was able to purchase pre FDA approval!!
Now it's over to the team to smash sales out of the park. Keep an eye on the influencer scene to see how BOT fares in the marketing next quarter!
Get it Vince!!!!!
Ann: FDA Approves Sofdra, page-240
-
- There are more pages in this discussion • 262 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.0¢ |
Change
-0.005(1.45%) |
Mkt cap ! $615.4M | |||
| Open | High | Low | Value | Volume |
| 34.0¢ | 34.0¢ | 32.8¢ | $1.949M | 5.840M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2985 | 33.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.0¢ | 420471 | 4 |
View Market Depth
| Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |